Table 1
Predicted net survival (NS) estimates, by selected cancer type and survival duration, ages 15 to 99 years at diagnosis, Canada excluding Quebec, 2012 to 2014^{Table 1 Note †}

Table 1
Predicted net survival (NS) estimates, by selected cancer type and survival duration, ages 15 to 99 years at diagnosis, Canada excluding Quebec, 2012 to 2014†
Table summary
This table displays the results of Predicted net survival (NS) estimates. The information is grouped by Cancer (appearing as row headers), Survival duration, 1 year, 5 years, 10 years, NS (%) and 95% confidence interval, calculated using from and to units of measure (appearing as column headers).
Cancer	Survival duration
	1 year			5 years			10 years
	NS (%)	95% confidence interval		NS (%)	95% confidence interval		NS (%)	95% confidence interval
	NS (%)	from	to	NS (%)	from	to	NS (%)	from	to
Tongue	83	82	85	63	61	65	55	52	58
Esophagus	42	41	44	15	14	16	12	10	13
Stomach	51	50	52	28	27	29	27	25	29
Small intestine	73	71	75	56	53	59	46	42	50
Colon	81	81	81	65	64	66	61	59	62
Rectum	86	85	86	66	65	67	62	60	63
Anus	87	85	89	64	61	67	56	52	61
Liver	45	44	47	19	18	20	13	12	15
Pancreas	28	27	29	8	7	9	7	6	8
Larynx	84	83	86	62	59	64	49	46	53
Lung and bronchus	44	44	45	19	18	19	13	13	13
Soft tissue (including heart)	80	78	81	61	59	63	57	54	60
Melanomas of the skin	96	95	96	88	87	88	87	85	88
Breast	97	97	97	88	88	89	82	81	83
Cervix uteri	88	87	89	72	70	74	67	65	69
Uterus (body, NOS)	93	93	94	83	83	84	80	79	82
Ovary	76	74	77	45	44	47	36	35	38
Prostate	97	97	98	93	92	93	90	89	90
Testis	98	97	99	97	96	97	96	94	98
Bladder (including in situ)^{Table 1 Note ‡}	89	88	89	75	74	76	66	63	69
Kidney and renal pelvis	84	83	84	71	70	72	63	61	64
Brain	48	46	49	21	19	22	15	14	16
Thyroid	99	98	99	98	97	98	97	96	98
Hodgkin lymphoma	92	91	93	86	84	87	81	78	83
Non-Hodgkin lymphoma	80	80	81	68	67	69	59	56	61
Multiple myeloma	76	75	77	44	43	46	32	30	34
Chronic lymphocytic leukemia	94	93	94	83	81	84	67	65	70
Acute myeloid leukemia	42	40	44	21	19	22	18	17	20
Chronic myeloid leukemia	83	81	85	60	57	63	50	47	54
Mesothelioma	41	38	44	7	6	9	5	4	7
Note † data from Quebec have not been submitted to the Canadian Cancer Registry since the 2010 data year; NS estimates predicted using the period method Return to note † referrer Note ‡ the province of Ontario did not submit in situ bladder cancer cases to the Canadian Cancer Registry prior to the 2010 data year Return to note ‡ referrer NOS=not otherwise specified Sources: Canadian Cancer Registry death linked file (1992-2014); life tables.

Date modified:: 2018-09-19

Language selection

Search and menus

Search

Table 1
Predicted net survival (NS) estimates, by selected cancer type and survival duration, ages 15 to 99 years at diagnosis, Canada excluding Quebec, 2012 to 2014^{Table 1 Note †}

Table 1 Predicted net survival (NS) estimates, by selected cancer type and survival duration, ages 15 to 99 years at diagnosis, Canada excluding Quebec, 2012 to 2014Table 1 Note †

Note of appreciation

Standards of service to the public

Copyright

Table 1
Predicted net survival (NS) estimates, by selected cancer type and survival duration, ages 15 to 99 years at diagnosis, Canada excluding Quebec, 2012 to 2014^{Table 1 Note †}